Abeona Therapeutics, Inc updates registry record NCT07717736: not yet recruiting
A record notice: the source is linked, and no summary was written because none passed the fact check.
The ClinicalTrials.gov record NCT07717736 ("Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds"), led by Abeona Therapeutics, Inc, was updated on July 21, 2026 and lists its status as not yet recruiting. readthrough could not produce a summary that passed its fact check, so this notice carries only what the registry states. Read the record: https://clinicaltrials.gov/study/NCT07717736
Fact check notes
- NoticeThe fact check could not support 4 of 5 sentences in the draft, so no summary was published.
- NoticeThis notice was built from the record's own index, not written by the model.
This is a record notice. readthrough could not write a summary that passed its fact check, so the headline and text above come from the record’s own index. The source is linked. Not investment advice.